July 31, 2026 Colgate-Palmolive Co. Reports 2nd Quarter 2026 Results: A Mixed Bag of Performance Colgate-Palmolive's Q2 2026 report reveals a 4.9% increase in net sales, reaching $5.36 billion, but GAAP EPS fell by 5% to $0.86. Despite challenges, market leadership in oral care remains strong, and margin improvements signal positive operational management.
July 17, 2026 Colgate-Palmolive Prepares for a Key Earnings Call: Insights and Expectations Colgate-Palmolive will host its Q2 earnings call on July 31, 2026, featuring key executives discussing the company's performance, strategies, and sustainability efforts. Investors can access the live webcast and recorded version through the investor relations website.
June 11, 2026 Colgate-Palmolive Declares Quarterly Dividend Amidst Continued Commitment to Innovation and Sustainability On June 11, 2026, Colgate-Palmolive declared a quarterly dividend of $0.53, reflecting its robust financial health and longstanding commitment to shareholders. The company emphasizes its dedication to sustainability and innovation, reinforcing its status in the consumer goods sector.
May 20, 2026 Colgate-Palmolive Prepares for dbAccess Global Consumer Conference with Key Leadership Participation Colgate-Palmolive is set to participate in the dbAccess Global Consumer Conference, featuring key executives discussing the company's strategic direction and sustainability efforts. The event will provide valuable insights for investors and stakeholders about Colgate's ongoing innovations and community outreach programs.
May 01, 2026 Colgate-Palmolive Reports Strong Q1 2026 Results Amidst Market Challenges Colgate-Palmolive's Q1 2026 results show an 8.4% increase in net sales to $5.324 billion, driven by strong organic sales. Despite a decrease in EPS, the company maintains market leadership in oral care and showcases robust cash flow to support future growth.
May 01, 2026 Colgate-Palmolive Co. Reports Robust Q1 2026 Results Amidst Geopolitical Challenges Colgate-Palmolive reported a robust 8.4% increase in Q1 2026 sales, totaling $5.32 billion, driven by growth in various segments. Despite geopolitical challenges, the company remains focused on strategic initiatives for future growth.
April 27, 2026 Colgate-Palmolive Set to Host Key Financial Events: Q1 Earnings Call and Annual Stockholders Meeting Colgate-Palmolive will host its Q1 earnings call on May 1, 2026, at 8:00 a.m. ET, followed by the Annual Stockholders Meeting on May 8. Investors can join via webcast to discuss financial performance and sustainability initiatives.
April 17, 2026 Colgate-Palmolive Announces Earnings Conference Call for Q1 2026 Colgate-Palmolive will host its Q1 2026 earnings conference call on May 1, 2026. Leaders will discuss financial performance, strategies, and sustainability efforts. Access the webcast via the Investor Center.
March 12, 2026 Colgate-Palmolive Announces Quarterly Dividend Increase and New Board Appointment Colgate-Palmolive has announced a quarterly dividend increase to $0.53 per share, effective May 2026, alongside the appointment of Dr. Christopher Boerner to its Board. These moves reflect the company's commitment to shareholder value and strong leadership as it continues to thrive in the consumer goods sector.
February 25, 2026 Colgate-Palmolive to Participate in UBS Global Consumer and Retail Conference Colgate-Palmolive will participate in the UBS Global Consumer and Retail Conference on March 11, 2026, featuring a fireside chat with John Faucher. This event will highlight the company’s commitment to sustainability and community health initiatives, along with strategic growth plans.
February 23, 2026 Colgate-Palmolive Company Reports 2025 Annual Results: A Year of Challenges and Strategic Growth Colgate-Palmolive's 2025 annual report reveals a 1.4% increase in net sales to $20.38 billion despite declining net income due to significant charges. The company emphasizes sustainability and innovation while navigating economic challenges.
February 06, 2026 Colgate-Palmolive Prepares for Key Presentation at CAGNY Conference Colgate-Palmolive will present its strategic vision at the CAGNY Conference on February 20, 2026, featuring insights from CEO Noel Wallace. The company emphasizes sustainability and innovation while showcasing its extensive brand portfolio.
January 30, 2026 Colgate-Palmolive Co Reports Mixed Results for 2025: A Year of Resilience Amid Challenges Colgate-Palmolive's financial results for 2025 highlight a 1.4% increase in net sales, despite a significant 25% decline in GAAP EPS due to one-time charges. The company's operational efficiency led to record cash flow, supporting shareholder returns and indicating resilience amidst challenges.
January 20, 2026 Colgate-Palmolive Teams Up with WHO Foundation to Enhance Global Oral Health Colgate-Palmolive has announced a multi-year partnership with the WHO Foundation to enhance global oral health. This initiative focuses on education, policy support, and increasing awareness to address oral health neglect, especially among vulnerable populations.
December 10, 2025 Colgate-Palmolive Declares Quarterly Dividend: A Commitment to Shareholder Value On December 10, 2025, Colgate-Palmolive declared a quarterly cash dividend of $0.52, payable on February 13, 2026. The company maintains a legacy of over 130 years of uninterrupted dividend payments, underscoring its financial health and commitment to shareholders while focusing on sustainability and community initiatives.
November 18, 2025 Colgate-Palmolive Engages Investors at Morgan Stanley Conference Colgate-Palmolive will engage investors at the Morgan Stanley Conference on December 2, 2025, sharing insights on growth strategies and sustainability initiatives. The company's commitment to innovation in oral and personal care, along with its efforts in reducing plastic waste, will be key discussion points.
October 31, 2025 Colgate-Palmolive Company Reports Steady Growth in Q3 2025 Colgate-Palmolive reported modest growth in Q3 2025 with net sales of $5.131 billion. Despite exiting the private label pet segment, the company maintains strong market leadership in oral care. Operational efficiency and strategic adjustments signal a cautious but optimistic future outlook.
October 31, 2025 Colgate-Palmolive Co. Reports Q3 2025 Earnings: A Mixed Bag Amidst Global Challenges Colgate-Palmolive's Q3 2025 earnings report shows a 2% increase in net sales despite facing inflation and geopolitical tensions. The company remains focused on innovation and operational efficiency to navigate ongoing challenges.
October 21, 2025 Colgate-Palmolive Set to Announce Q3 Earnings - Key Details Ahead of the Call Colgate-Palmolive is set to announce its Q3 earnings on October 31, 2025, with a live webcast hosted by top executives. The company continues to focus on sustainability and community initiatives, highlighting its commitment to improving global health.
August 01, 2025 Colgate-Palmolive Co. Reports Steady Growth Amidst Economic Challenges in Q2 2025 Colgate-Palmolive reported a modest increase in net sales of 1.0% in Q2 2025, driven by strategic price increases despite economic pressures. The company remains committed to innovation and sustainability, even as it navigates challenges such as geopolitical tensions and inflation.
May 08, 2025 Cresco Labs Postpones First Quarter 2025 Earnings Release Cresco Labs has postponed its Q1 2025 earnings call originally scheduled for May 9, 2025, to ensure accurate financial reporting. The company remains focused on transparency and will file interim financial statements by May 30, 2025.
April 29, 2025 Colgate-Palmolive Sets the Stage for Strategic Insights at Goldman Sachs Global Staples Forum Colgate-Palmolive will feature key executives in a fireside chat at the Goldman Sachs Global Staples Forum, discussing strategies in pet nutrition and sustainability. Investors can access the live webcast and recorded version for future insights.
April 29, 2025 Cresco Labs Set to Unveil First Quarter 2025 Financial Results Cresco Labs Inc. is set to announce its financial results for Q1 2025 on May 9, 2025, alongside a conference call to discuss key business developments. The company continues to lead in the cannabis industry with a strong brand portfolio and community initiatives aimed at normalizing cannabis use.
April 28, 2025 Colgate-Palmolive to Host Annual Meeting of Stockholders Colgate-Palmolive is set to host its 2025 Annual Meeting of Stockholders on May 9, offering a live webcast for investors. The meeting will focus on the company’s initiatives in sustainability and innovation, highlighting its commitment to a healthier future.
April 25, 2025 Colgate-Palmolive Company Reports Q1 2025 Results: Mixed Financial Performance Amidst Market Challenges Colgate-Palmolive's Q1 2025 report reveals a 3.1% decline in net sales yet a 2% increase in earnings per share. The company shows resilience with organic sales growth and improved profit margins despite market challenges.
April 11, 2025 Colgate-Palmolive Set to Announce First Quarter Earnings on April 25, 2025 Colgate-Palmolive will host a live webcast for its Q1 earnings on April 25, 2025. Key executives will discuss financial performance and sustainability initiatives, reflecting the company's commitment to innovation and community well-being.
March 12, 2025 Cresco Labs Reports Record Cash Flow for 2024: A Year of Strategic Growth Cresco Labs has reported record financial results for 2024, including $724 million in revenue and $132 million in operating cash flow. The company's disciplined strategy and market leadership position indicate strong future growth potential as they expand into new markets.
March 10, 2025 Cresco Labs Secures Kentucky's Largest Medical Cannabis Cultivation License Cresco Labs has acquired Kentucky's largest Tier 3 medical cannabis cultivation license, marking a key milestone in the state's burgeoning cannabis industry. With plans for a state-of-the-art facility, the company aims to leverage the projected market growth to strengthen its presence and brand recognition in the region.
March 03, 2025 Cresco Labs Set to Unveil Q4 2024 Financial Results Cresco Labs is set to reveal its Q4 2024 financial results on March 12, 2025, followed by a conference call to discuss the findings. The company continues to lead in the cannabis industry with a focus on brand development and community engagement.
February 26, 2025 Colgate-Palmolive to Address Investors at UBS Global Consumer and Retail Conference Colgate-Palmolive will present at the UBS Global Consumer and Retail Conference on March 12, 2025, featuring insights from John Faucher. The company emphasizes innovation and sustainability, highlighting its impact on consumer health and environmental stewardship.
February 18, 2025 Colgate-Palmolive Expands Pet Nutrition Portfolio with Prime100 Acquisition Colgate-Palmolive announced its acquisition of Prime100 to strengthen its Hill’s Pet Nutrition division in the fresh pet food sector. This strategic move aims to enhance growth and distribution while meeting pet owners' dietary needs. The deal is set to close in 2025, pending regulatory approval.
February 13, 2025 Colgate-Palmolive Co. 2024 Annual Report: A Resilient Year Amid Challenges Colgate-Palmolive's 2024 annual report reveals a net sales increase of 3.3% to $20.1 billion, driven by effective pricing and volume strategies. The company maintains a positive outlook despite geopolitical challenges, focusing on innovation and market expansion.
February 12, 2025 SWOT Analysis of Colgate-Palmolive Co in 2025 This SWOT analysis of Colgate-Palmolive in 2025 highlights its market strengths and brand loyalty while addressing challenges like legal issues and market competition. The company has opportunities in emerging markets and sustainability, but must navigate geopolitical and regulatory threats.
February 10, 2025 Colgate-Palmolive Partners with ADA Foundation for 23rd Year of Give Kids A Smile Program Colgate-Palmolive partners with the ADA Foundation for the 23rd year of the Give Kids A Smile program, providing free dental services to underserved children. With nearly 1,100 events planned in 2025, the initiative aims to improve oral health and education for over 325,500 kids nationwide.
February 07, 2025 Colgate-Palmolive to Present at the Consumer Analyst Group of New York Conference Colgate-Palmolive will present at the CAGNY Conference on February 21, 2025, featuring insights from CEO Noel Wallace. The company highlights its commitment to sustainability and innovation across its global operations.
October 25, 2024 Colgate-Palmolive Co. Reports Steady Growth in Q3 2024 Colgate-Palmolive's Q3 2024 results showcase a 2.4% increase in sales, reaching $5.03 billion, driven by volume growth and price hikes. Despite facing geopolitical challenges and rising costs, the company remains committed to innovation and market expansion.
July 26, 2024 Colgate-Palmolive Reports Strong Q2 2024 Results Amidst Challenging Conditions Colgate-Palmolive's Q2 2024 report reveals net sales of $5.058 billion and a 45.7% increase in net income. The company navigates economic challenges while focusing on strategic growth.
April 26, 2024 Colgate-Palmolive Company Reports Strong Q1 2024 Financial Results Colgate-Palmolive reported a 6.2% increase in net sales for Q1 2024, reaching $5.065 billion. The company's net income rose to $683 million, reflecting strong performance despite global challenges. Key segments showed varied growth, with Latin America leading in sales increases.
